Dr. Kalika P. Sarma
Claim this profileCarle Cancer Center
Studies Cancer
Studies Breast Cancer
8 reported clinical trials
23 drugs studied
Area of expertise
1Cancer
Stage IV
Stage II
Stage III
2Breast Cancer
HER2 positive
Stage II
Stage I
Affiliated Hospitals
Carle Cancer Center
Rush - Copley Medical Center
Clinical Trials Kalika P. Sarma is currently running
Chemotherapy + Radiotherapy
for Esophageal and Gastric Cancer
This phase III trial studies how well the addition of radiotherapy to the usual treatment (chemotherapy) works compared to the usual treatment alone in treating patients with esophageal and gastric cancer that has spread to a limited number of other places in the body (oligometastatic disease). Radiotherapy uses high energy x-rays, gamma rays, or protons to kill tumor cells and shrink tumors. Drugs used in usual chemotherapy, such as leucovorin, 5-fluorouracil, oxaliplatin, and capecitabine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Adding radiotherapy to the usual chemotherapy may work better compared to the usual chemotherapy alone in treating patients with esophageal and gastric cancer.
Recruiting2 awards Phase 320 criteria
Whole Brain Radiotherapy + Stereotactic Radiosurgery
for Brain Metastasis
This phase III trial compares the effect of adding whole brain radiotherapy with hippocampal avoidance and memantine to stereotactic radiosurgery versus stereotactic radiosurgery alone in treating patients with cancer that has spread to the brain and come back in other areas of the brain after earlier stereotactic radiosurgery. Hippocampus avoidance during whole-brain radiation therapy decreases the amount of radiation that is delivered to the hippocampus, which is a brain structure that is important for memory. The medicine memantine is also often given with whole brain radiation therapy because it may decrease the risk of side effects of radiation on thinking and memory. Stereotactic radiosurgery delivers a high dose of radiation only to the small areas of cancer in the brain and avoids the surrounding normal brain tissue. Adding whole brain radiotherapy with hippocampal avoidance and memantine to stereotactic radiosurgery may be effective in shrinking or stabilizing cancer that has spread to the brain and returned in other areas of the brain after receiving stereotactic radiosurgery.
Recruiting2 awards Phase 312 criteria
More about Kalika P. Sarma
Clinical Trial Related4 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Kalika P. Sarma has experience with
- Cisplatin
- Fluorouracil
- Intensity-Modulated Radiation Therapy
- Radiation Therapy
- Stereotactic Radiosurgery
- Whole-Brain Radiotherapy
Breakdown of trials Kalika P. Sarma has run
Cancer
Breast Cancer
Lung Cancer
Brain Metastasis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kalika P. Sarma specialize in?
Kalika P. Sarma focuses on Cancer and Breast Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage II.
Is Kalika P. Sarma currently recruiting for clinical trials?
Yes, Kalika P. Sarma is currently recruiting for 5 clinical trials in Urbana Illinois. If you're interested in participating, you should apply.
Are there any treatments that Kalika P. Sarma has studied deeply?
Yes, Kalika P. Sarma has studied treatments such as Cisplatin, Fluorouracil, Intensity-Modulated Radiation Therapy.
What is the best way to schedule an appointment with Kalika P. Sarma?
Apply for one of the trials that Kalika P. Sarma is conducting.
What is the office address of Kalika P. Sarma?
The office of Kalika P. Sarma is located at: Carle Cancer Center, Urbana, Illinois 61801 United States. This is the address for their practice at the Carle Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.